Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib
To access this article, please choose from the options below
PII: S1368-7646(09)00048-X
doi:10.1016/j.drup.2009.07.001
© 2009 Elsevier Ltd. All rights reserved.
